Tag

Johnson & Johnson

merger & acquisition

Johnson & Johnson to Acquire V-Wave
mergers & acquisitions

J&J Completes $1.25B Acquisition of Yellow Jersey Therapeutics
M&A

J&J Completes Acquisition of Proteologix, Inc.
merger & acquisition

J&J Completes Acquisition of Shockwave Medical
healthcare

J&J to Lead in Atopic Dermatitis Treatment with Recent Acquisition
heart

J&J to Acquire Shockwave Medical
trophy

J&J Honors MIT Scientist with Dr. Paul Janssen Award for Biomedical Research
merger and acquisition

J&J to Acquire Ambrx
Johnson & Johnson

Johnson & Johnson Updates Brand & Visual Identity
Kenvue

Kenvue’s First Day as Independent Company
business relocation

J&J Spinoff Kenvue Locating HQ in Summit
legal money

J&J Offers 25-Year, $8.9B Payment to Resolve Current and Future Talc Claims
leader

Reed Named Executive Vice President, Pharmaceuticals, R&D at J&J
Joaquin Duato

Johnson & Johnson Names CEO Duato Chairman of the Board
Johnson & Johnson

Johnson & Johnson to Acquire Abiomed
healthcare

J&J’s Planned New Consumer Health Company Named Kenvue
boardroom

JNJ Appoints Merlo as Non-Executive Chair Designate
law

J&J’s General Counsel to Retire at Year’s End
coronavirus vaccine

J&J COVID-19 Vax to be Manufactured by an African Company
healthcare vaccines

J&J Vax Shows Durable Protection Against COVID
COVID vaccine booster

J&J COVID-19 Booster Demonstrates 85% Effectiveness against Hospitalization
Innovate Health

J&J to Spin Off its Consumer Health Products Business
healthcare vaccine

J&J COVID-19 Booster Recommended for EUA by FDA Advisory Committee
ceo

Joaquin Duato to Take Over as Chief Executive Officer of Johnson & Johnson